AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 283: H2130-H2139, 2002. First published July 26, 2002; doi:10.1152/ajpheart.00196.2002
0363-6135/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/H2130    most recent
00196.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodsky, S. V.
Right arrow Articles by Goligorsky, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodsky, S. V.
Right arrow Articles by Goligorsky, M. S.
Vol. 283, Issue 5, H2130-H2139, November 2002

Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells

Sergey V. Brodsky1, Shujuan Gao2, Hong Li2, and Michael S. Goligorsky1

1 Department of Medicine, New York Medical College, Valhalla 10595; and 2 Department of Pharmacology, State University of New York, Stony Brook, New York 11794


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The accumulated ultrastructural and biochemical evidence is highly suggestive of the existence of mitochondrial nitric oxide (NO) synthase (mtNOS), where local production of NO regulates the electron transport along the respiratory chain. Here, the functional competence of mtNOS in situ in a living cell was examined using an intravital fluorescent NO indicator, 4,5-diaminofluorescein, employing a new procedure for loading it into the mitochondria to demonstrate local NO generation in undisrupted endothelial cells and in isolated mitochondria as well as in human embryonic kidney cells stably expressing endothelial NOS. With the use of this approach, we showed that endothelial cells incubated in the presence of high concentration of D-glucose (but not L-glucose) are characterized by the reduced NO synthetic function of mitochondria despite the unaltered abundance of the enzyme. In parallel, mitochondrial generation of superoxide was augmented in endothelial cells incubated in the presence of a high concentration of D-glucose. Both the NO generation and superoxide production in hyperglycemic environment could be restored to control levels by treating cells with a cell-permeable superoxide dismutase mimetic. In addition, enhanced mitochondrial superoxide production could be suppressed with an inhibitor of NOS in stimulated endothelial cells. In conclusion, the data 1) provide direct evidence of mitochondrial NO production in endothelial cells, 2) demonstrate its suppression and enhanced superoxide generation in hyperglycemic environment, and 3) provide evidence that "uncoupled" mtNOS represents an important source of superoxide anions in endothelial cells incubated in high glucose-containing medium.

mitochondria; nitric oxide synthase; superoxide anions


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

SINCE THE DISCOVERY of the endothelium-derived relaxing factor and its identification with nitric oxide (NO) (11, 18, 27), the spectrum of signaling functions attributed to this gaseous messenger is continuously growing (35). It has been recognized that NO synthase (NOS) is associated, in addition to the well-established plasmalemmal localization, with mitochondria of different cell types. Kobzik et al. (19) observed that normal skeletal muscle fibers express two types of NOS, endothelial (eNOS) and neuronal NOS, in a spatially distinct pattern. The endothelial isoform was colocalized with the mitochondrial marker succinate dehydrogenase and participated in calcium-dependent inhibition of oxygen consumption. With the use of immunoelectron microscopy of isolated mitochondrial preparations obtained from the rat heart, liver, and kidney and stained with antibodies directed against eNOS, Bates et al. (2, 3) found that 63-86% of mitochondria displayed the silver-gold signal. Electron paramagnetic resonance studies of isolated rat liver mitochondria provided functional support to the idea that mitochondrial NOS (mtNOS) was capable of generating NO (13, 14). Together with existing data on NO modulation of the electron transport along the respiratory chain (5, 7), the potential role of mtNOS in the regulation of oxidative phosphorylation has been deduced (3). In an attempt to measure NO production in mitochondria of nondisrupted cells, we sought to establish technical approaches utilizing an NO-sensitive fluorophore, 4,5-diaminofluorescein diacetate (DAF; see METHODS) and applied them to the vascular endothelium. Specifically, one of the questions to be addressed was related to NO generation by mtNOS in endothelial cells subjected to the hyperglycemic microenvironment, because it has been suggested that suppressed NO production and enhanced generation of superoxide anions could be responsible for diverse metabolic derangements occurring in the vascular endothelium (25).


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Materials. DAF and manganese (III) tetrakis (4-benzoic acid) porphyrin were purchased from Alexis (San Diego, CA). A-23187, bradykinin, and Nomega -nitro-L-arginine (L-NNA) were purchased from Sigma (St. Louis, MO). 2',7'-Dichlorodihydrofluorescin diacetate (DDF) and MitoTracker red were manufactured by Molecular Probes (Eugene, OR).

Cell cultures. Human umbilical vein endothelial cells (HUVEC) were obtained from Clonetics and maintained under conditions of 37°C and 5% CO2 in EBM-2 medium (Clonetics) supplemented with 2% serum and containing 5 mM D-glucose. HUVEC were used between passages 2 and 5. Rat renal microvascular endothelial cells (RMVEC) were previously established and characterized by our laboratory; these simian virus-40-immortalized cells established from explant cultures of microdissected rat renal resistance arteries incorporate acetylated low-density lipoprotein, express immunodetectable von Willebrand antigen, and are capable of capillary tube formation (36). Wild-type and stably expressing human eNOS human embryonic kidney (HEK) cells, established by Liu et al. (24), were kindly provided by Dr. S. S. Gross (Cornell Medical College).

Cell and mitochondrial loading with DAF and DDF. HUVEC or RMVEC were cultured in glass-bottom dishes (Becton-Dickinson; Belford, MA). Cell loading was accomplished by incubating HUVEC with 5 µM DAF for 30 min (4, 20) or 10 µM DDF for 30 min at 37°C in cell culture medium (40, 41). Thus loaded cells were used either for measurements of intracellular NO or O<UP><SUB>2</SUB><SUP>−</SUP></UP> or for pulse-chase mitochondrial loading. Briefly, after being washed with sterile PBS to remove fluorophores, cells were further incubated in fresh culture medium with hourly inspection of the distribution of fluorophores. Usually, 6-8 h after initiation of DAF washout and 1-2 h after DDF washout, diffuse cytoplasmic fluorescence disappeared and only mitochondria-confined fluorescence was retained, as confirmed by its colocalization with MitoTracker fluorescence and by cell fractionation studies (see RESULTS). MitoTracker red (25 nM) was loaded for 10 min at 37°C in cell culture medium. Subsequently, cells were washed with PBS and incubated in Krebs-HEPES buffer. L-NNA, antimycin, A-23187, bradykinin, or L-arginine were added after a baseline recording at the concentrations specified in RESULTS. Isolated mitochondria were loaded with DAF (5 µM) for 20 min in the mitochondrial buffer [containing (in mM) 225 sucrose, 5 MgCl2, 20 KCl, 10 potassium phosphate, 0.1 CaCl2, 2 succinate, and 20 HEPES; pH 7.4] (13, 14), and fluorescence intensity was measured using a plate reader.

Quantitative intravital monitoring of NO and superoxide production. Intravital fluorescence microscopy of HUVEC or RMVEC was performed using a Nikon epifluorescence inverted microscope (Diaphot) equipped with a silicon intensified tube camera (Hamamatsu). Cells were illuminated for 30 ms at a wavelength of 485 nm in 15-s intervals using an automatic shutter (Lambda 10-2, Sutter Instruments) interfaced to Image-1-fluor software (Universal Imaging). [It is important to emphasize that DAF is photoactivatable; therefore, only keeping the duration of illumination to the minimum allows the avoidance of a NO-independent rise in fluorescence intensity (4)]. Images were collected at the wavelength of 530 nm using the appropriate dichroic mirror, stored, and analyzed using Image-1 software. Confocal microscopy was performed using an Odyssey system (Noran Instruments) equipped with Metamorph software (Universal Imaging) and analyzed using a Silicon Graphic system.

Cell fractionation experiments. All procedures were carried out at 4°C, according to previously established techniques (9). Cells were washed twice with ice-cold PBS and scraped into sucrose-EGTA-MOPS (SEM) buffer (0.25 M sucrose, 1 mM EGTA, and 10 mM MOPS; pH 7.2). Cells were homogenized with a Dounce homogenizer (30 strokes), the lysate was centrifuged at 400 g for 10 min in a Beckman J-20 rotor, and the pellet was resuspended in SEM buffer and subjected to centrifugation at 10, 000 g for 10 min. The pellet containing the mitochondrial fraction, as confirmed by the enrichment of mitochondrial marker enzymes (see RESULTS), was washed with SEM buffer twice and resuspended in the same buffer. The postmitochondrial supernatant fraction was designated as the cytosolic fraction. Western blot analysis of lysates prepared from isolated mitochondria or whole cells was performed as previously described (22). Briefly, SDS-PAGE was performed using a 4-12% Tris-glycine gel (Invitrogen) under reducing conditions. Proteins were transferred to nitrocellulose membranes and incubated with primary antibodies (anti-human cytochrome c oxidase subunit II monoclonal antibody from Molecular Probes, 1:1,000 dilution; anti-eNOS antibody from Transduction Laboratories, 1:500 dilution; and anti-Na+-K+-ATPase alpha 1-subunit monoclonal antibody from Research Diagnostics, 1:250 dilution). The blotted bands were incubated with horseradish peroxidase-conjugated IgG. Bands were detected with an enhanced chemiluminescence detection system (Pierce).

For isolation of rat liver mitochondria, 1 g of rat liver was obtained from Zucker diabetic fatty (ZDF) and lean nondiabetic (ZL) rats and homogenized in the buffer containing 10 mM Tris · HCl, 250 mM sucrose, and 0.1 mM EDTA by applying 20-30 strokes, according to Li et al. (23). The nuclei and debris were removed by centrifugation at 610 g for 10 min. The supernatant was centrifuged at 8,600 g for 10 min. The mitochondrial pellet was washed with the above buffer three times and used immediately for fluorescence studies.

Fluorescence plate reader assay. Assays were performed in 96-well microtiter plates (Falcon) using a CytoFluor II fluorometer (PerSeptive Biosystem; Framingham, MA). Both NO and O<UP><SUB>2</SUB><SUP>−</SUP></UP> release was measured with a fluorescein filter set (excitation 485 ± 20 nm; emission 530 ± 25 nm) in the plate reader. Cells or isolated mitochondria were loaded with fluorophores as described above for DAF and DDF; L-NNA or antimycin was added at the concentrations specified in RESULTS. A-23187 or calcium-calmodulin were added after 20 min of baseline recording. Data were analyzed using the Excel and Microcal Origin software packages.

Statistical analysis. Statistical analysis was performed using paired or unpaired t-test and/or ANOVA, followed by Tukey's post-test with P < 0.05 considered statistically significant. All values are presented as means ± SE. All experiments were repeated at least three times.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Detection of intracellular NO production using DAF fluorescence. Macrovascular and microvascular endothelial cells, HUVEC and RMVEC, respectively, were loaded with DAF, and real-time changes in fluorescence intensity were monitored using short cycles of illumination, as detailed in METHODS. Under these conditions, recordings showed a stable baseline indicative of negligible photoactivation of DAF. Application of a calcium ionophore, A-23187 (5 µg/ml), resulted in increased fluorescence of both cell types (Fig. 1, A and B), which was reversed by the addition of a NOS inhibitor, 1 mM L-NNA. The effect of A-23187 was significantly blunted in cells pretreated with 1 mM L-NNA (Fig. 1, A and B). Bradykinin-stimulated HUVEC (10 µM) responded with increased fluorescence of DAF, which was similarly prevented by L-NNA pretreatment (Fig. 1C).


View larger version (20K):
[in this window]
[in a new window]
  		Fig. 1.   4,5-Diaminofluorescein (DAF) fluorescence in macrovascular [human umbilical vein endothelial cells (HUVEC)] and microvascular [rat renal microvascular endothelial cells (RMVEC)] endothelial cells. A: in HUVEC, 5 µg/ml of the calcium ionophore A-23187 (n = 10) elicited a Nomega -nitro-L-arginine (L-NNA)-inhibitable (n = 10, 1 mM L-NNA) increase in DAF fluorescence intensity. [Inset, representative dose-response curve of DAF fluorescence upon the addition of different concentrations of sodium nitroprusside (SNP).] *P < 0.05 compared with L-NNA-treated cells. B: in RMVEC, A-23187 produced a quantitatively and qualitatively similar response (n = 9), which was blocked by pretreatment with L-NNA (1 mM, n = 7) and reversed by posttreatment with L-NNA (n = 7). *P < 0.05 compared with L-NNA-pretreated cells; #P < 0.05 compared with L-NNA-nontreated cells. C: bradykinin (BK; 10 µM) elicited in HUVEC a comparable to A-23187 increase in the fluorescence intensity (n = 10), which was blocked by pretreatment with L-NNA (1 mM, n = 9). *P < 0.05 compared with L-NNA-treated cells.

Detection of NO in mitochondria. In a series of pulse-chase studies of DAF washout from live endothelial cells, it was observed that after 8 h of incubating DAF-loaded cells in the fluorophore-free culture medium, cell fluorescence, hitherto diffuse cytoplasmic, was redistributed to a network of elongated intracellular structures. Costaining with a fluorescent mitochondrial marker, MitoTracker, showed a conspicuous colocalization of fluorophores reaching 84.8% (from 23.2%) by 8 h (Fig. 2A). These data suggested that DAF was retained in the mitochondria in the process of its washout from the cytoplasm.


View larger version (27K):
[in this window]
[in a new window]
  		Fig. 2.   Pulse-chase loading of HUVEC with DAF and measurement of mitochondrial nitric oxide (NO) production. A: cells were loaded with DAF, as detailed in METHODS, for 30 min, washed, and incubated for different periods of time in fresh medium devoid of the fluorophore. At different times during washout, a mitochondrial marker, MitoTracker red, was added to the incubation medium, and dual-wavelength confocal microscopy was performed. Initially, DAF fluorescence was uniformly distributed throughout the cytoplasm. Six hours after initiation of washout, DAF fluorescence showed a flocculated appearance but only partially colocalized with MitoTracker (data not shown). After 8 h of washout, DAF fluorescence was almost entirely confined to the mitochondrial compartment, as judged from the colocalization of both fluorophores (merged images). B: HUVEC (n = 8) were loaded with DAF for 45 min or pulse chase loaded with DAF (8 h), followed by cell fractionation and measurement of DAF fluorescence [in arbitrary units (a.u.)/mg protein] in individual fractions (Mt, mitochondria; PM, plasma membrane; CP, cytoplasmic fraction). Whereas initially DAF was present in all fractions, after 8 h of washout the fluorophore was highly enriched in the mitochondrial fraction. *P < 0.05 compared with mitochondrial fluorescence intensity. C: HUVEC were pulse chase loaded with DAF, and mitochondrial DAF fluorescence was monitored. A-23187 elicited an increase in DAF fluorescence (n = 11). Pretreatment with L-NNA blunted this response to A-23187 (n = 10). (Breaks in the graph are shown for the 10-min pretreatment with L-NNA.) *P < 0.05 compared with L-NNA-treated cells.

To confirm this conclusion, we fractionated HUVEC loaded with DAF and examined the distribution of DAF fluorescence in different fractions (Fig. 2B). After 45 min of cell loading, DAF fluorescence was highest in the mitochondrial fraction, whereas the plasma membrane fraction and the cytosol retained >50% of DAF fluorescence. In contrast, after similar DAF loading and 8 h of washout, fluorescence was predominantly associated with the mitochondrial fraction, with <20% fluorescence retained in association with the plasma membrane and the cytosolic fractions. Importantly, DAF fluorescence associated with the mitochondrial fraction showed only an insignificant decline after 8 h of washout, further confirming the validity of the procedure.

With the use of this loading protocol, NO responses of HUVEC were reexamined. A-23187 elicited a L-NNA-inhibitable increase in DAF fluorescence (Fig. 2C). Similar results were obtained in mitochondria isolated from HUVEC and studied using a fluorescence microplate reader (data not shown).

In an attempt to discern the source (mitochondrial vs. cytosolic) of A-23187-evoked NO production as detected by mitochondrially loaded DAF, the purity of isolated mitochondria was examined using Western blotting. A mitochondrial marker protein, cytochrome c oxidase, was enriched in mitochondrial fractions compared with the whole cell lysates (Fig. 4). Immunodetectable eNOS was present in mitochondrial fractions of HUVEC and a surrogate cell line expressing eNOS, HEK/eNOS cells, but only trace amounts of eNOS were detectable after prolonged exposure of X-ray film in the wild-type HEK cells (only after overexposing the film). Hence, eNOS is immunodetectable in mitochondrial fractions of HUVEC and HEK/eNOS cells.

We next compared DAF fluorescence in wild-type HEK and HEK cells stably trasfected with human eNOS. In wild-type HEK cells, mitochondrial loading with DAF resulted in a faint fluorescence and marginal changes in fluorescence intensity in response to 5 µg/ml A-23187 (Fig. 3A). This was in sharp contrast with HEK/eNOS cells, which exhibited mitochondrial DAF fluorescence and responded to 5 µg/ml A-23187 with an increase in DAF fluorescence intensity comparable to that seen in HUVEC. Changes in fluorescence intensity were inhibited by Nomega -nitro-L-arginine methyl ester (L-NAME) but not by Nomega -nitro-D-arginine methyl ester (D-NAME) (Fig. 3B).


View larger version (21K):
[in this window]
[in a new window]
  		Fig. 3.   Human embryonic kidney (HEK) cells, stably expressing human endothelial NO synthase (eNOS), exhibit Nomega -nitro-L-arginine methyl ester (L-NAME)-inhibitable mitochondrial NO production. A: effects of 5 µg/ml A-23187 on mitochondrial DAF fluorescence in HEK (n = 11) and HEK/eNOS (n = 11) cells. *P < 0.05 compared with HEK cells. B: effects of A-23187 on mitochondrial NO production in HEK/eNOS (n = 9) cells are inhibited by pretreatment with L-NAME (n = 11) but not with Nomega -nitro-D-arginine methyl ester (D-NAME; n = 10). *P < 0.05 compared with L-NAME-treated cells.

Mitochondrial generation of NO in a hyperglycemic environment. It has previously been demonstrated that NOS function is modified by reactive oxygen species (ROS) (8). Furthermore, there is growing evidence that the elevated glucose concentration results in oxidative stress (11), specifically, mitochondrial oxidative stress (21). Therefore, it was important to examine whether mitochondrial oxidative stress induced by hyperglycemia could affect NO generation by mtNOS. The above protocol provided the only existing technical means to address this question.

HUVEC were incubated in culture medium supplemented with 30 mM D-glucose (or L-glucose as a control for osmolality) for different periods of time, and mitochondrial NO generation was examined. The A-23187-stimulated increase in DAF fluorescence was blunted in the presence of 30 mM D-glucose, exhibiting a decrease in both the peak NO generation and the duration of the response (Fig. 5A). To evaluate the contribution of superoxide anions to the decreased mitochondrial NO production, in a separate series of experiments, D-glucose-treated HUVEC were cotreated with a cell-permeable superoxide dismutase mimetic, Mn-TBAP (50 µM), and mitochondrial NO production was examined. As shown in Fig. 5B, Mn-TBAP completely restored the mitochondrial ability to generate NO in response to A-23187. Western blot analysis of mitochondrial fractions obtained from HUVEC cultured in euglycemic or hyperglycemic environment with detection of mtNOS using anti-eNOS antibodies revealed that the decrease in NO production could not be attributed to the reduced expression of the enzyme in HUVEC incubated in the presence of 30 mM D-glucose (Fig. 5C).


View larger version (26K):
[in this window]
[in a new window]
  		Fig. 4.   Expression of eNOS and cytochrome c oxidase (COX) in mitochondrial and whole cell lysates prepared from HUVEC and HEK cells. Mt, lysates of the mitochondrial fraction; Cell, whole cell lysates; Gl5 and Gl30, 5 and 30 mM D-glucose, respectively; WT, wild type; eNOS, HEK-expressing eNOS.



View larger version (36K):
[in this window]
[in a new window]
  		Fig. 5.   Hyperglycemic environment inhibits mitochondrial NO production. A: HUVEC were incubated for 24-48 h in the presence of 30 mM D-glucose (D-Gl; n = 11), L-glucose (L-Gl) (25 mM + 5 mM D-glucose, n = 10) or 5 mM D-glucose (n = 11) and pulse chase loaded with DAF, and mitochondrial fluorescence was monitored. High D-glucose (but not L-glucose) resulted in a significant blunting of the A-23187-elicited increase in mitochondrial DAF fluorescence intensity. *P < 0.05 compared 5 mM D-glucose. B: pretreatment of HUVEC cultured for 24 h in 30 mM D-glucose (n = 12) with a cell-permeable superoxide dismutase mimetic, Mn-TBAP (50 µM, n = 13), restored mitochondrial NO production in response to A-23187. C: Western blot analysis of eNOS expression in whole cell and mitochondrial lysates. Cytochrome c oxidase expression was used as a marker of mitochondria. Note that incubation in 30 mM D-glucose did not affect the abundance of eNOS in either mitochondria or the whole cell. D: NO production by liver mitochondria isolated from Zucker diabetic fatty (ZDF) and control lean (ZL) rats. Differential NO responses in isolated liver mitochondria from diabetic and control rats are shown. Isolated mitochondrial preparations were obtained from the liver of ZDF and ZL rats. Mitochondria were loaded with DAF and stimulated with A-23187. Fluorescence was detected with a plate reader at different times after stimulation. Note that NO production by mitochondria obtained from ZDF rats was significantly blunted. *P < 0.05, ZDF vs. ZL rats, n = 9 in each group.

Similar results were obtained in HEK/eNOS cells. Mitochondrial loading with DAF of wild-type and eNOS-expressing HEK cells produced a drastically distinct staining: faint in HEK cells and bright in HEK/eNOS cells. Application of A-23187 to both cell types preincubated with 5 or 30 mM D-glucose for 24 h evoked a significant L-NAME-inhibitable increase in fluorescence intensity of DAF in HEK/eNOS cells but not in HEK cells (Fig. 6). However, cells pretreated with 30 mM D-glucose for 24 h showed a 50% blunting of responses to A-23187, similar to what was observed in HUVEC.


View larger version (19K):
[in this window]
[in a new window]
  		Fig. 6.   Influence of the ambient D-glucose concentration on DAF fluorescence intensity in HEK cells. HEK and HEK/eNOS cells incubated for 24 h in 5 or 30 mM D-glucose were loaded with DAF using the mitochondrial loading protocol. Basal (Bl) and A-23187-evoked (5 µg/ml) fluorescence (A23) were detected using a fluorescence plate reader. Experiments were performed in the presence or absence of either D-NAME or L-NAME. Note that HEK/eNOS cells exhibited higher fluorescence intensity at baseline (#P < 0.05 vs. HEK, n = 7) and responded to A-23187 with a L-NAME-inhibitable increase in fluorescence intensity (*P < 0.05 vs. HEK, n = 7). The responses observed in HEK/eNOS cells incubated in 30 mM D-glucose were blunted compared with cells in 5 mM D-glucose (**P < 0.05 vs. 30 mM D-glucose, n = 7).

To verify whether mitochondria obtained from diabetic animals also have a defect of mitochondrial NO production, 18-wk-old hyperglycemic ZDF and control ZL rats were used to prepare liver mitochondria. Isolated mitochondria were loaded with DAF, and the fluorescence intensity was studied in a 96-well plate reader under basal conditions and after application of A-23187. The data presented in Fig. 5D demonstrate that basal NO production by mitochondria isolated from ZDF rats was significantly reduced compared with ZL rats (basal NO production by ZL mitochondria was used for normalization of data). A-23187 elicited NO production in mitochondria isolated from both groups, but it remained drastically blunted in ZDF rats.

Mitochondrial generation of superoxide anions in a hyperglycemic environment. To further address the possibility of mitochondrial oxidative stress representing a cause of reduced NO production, we next applied the similar mitochondrial loading strategy to DDF. This nonfluorescent, cell-permeable compound acquires fluorescence properties upon oxidation and has been broadly used to detect ROS (40, 41). Specifically, cell loading was followed by a washout period, when fluorophore virtually disappeared from the cytoplasm but was retained in a tubular network. Dual labeling of HUVEC with MitoTracker and DDF, as detailed in METHODS, showed 79.9% (from 24.7%) colocalization of both fluorophores (Fig. 7A). Application of A-23187 to DDF-loaded HUVEC resulted in a modest increase in mitochondrial fluorescence intensity (Fig. 7B). When cells were treated with 30 mM D-glucose for 24 or 48 h, application of the calcium ionophore elicited a robust response, which was fivefold higher than that observed in HUVEC incubated in the euglycemic medium. There was no significant difference between responses observed after 24 or 48 h of treatment with D-glucose. L-Glucose added at the concentration of 30 mM did not reproduce the effects of the equivalent concentration of D-glucose (Fig. 7B). The exaggerated generation of superoxide anions in D-glucose-treated cells stimulated with A-23187 was significantly attenuated by pretreatment of HUVEC with a superoxide dismutase mimetic, Mn-TBAP (Fig. 7C). Furthermore, isolated liver mitochondria from 22-wk-old ZDF and ZL rats showed that basal and stimulated levels of superoxide produced in ZDF mitochondria were significantly higher than in ZL mitochondria (Fig. 7D).


View larger version (37K):
[in this window]
[in a new window]
  		Fig. 7.   Hyperglycemic environment enhances mitochondrial superoxide generation. A: pulse-chase mitochondrial loading with 2',7'-dichlorodihydrofluorescin diacetate (DDF). HUVEC were loaded with DDF, as detailed in METHODS, and transferred to fresh culture medium for different periods of time. Cells were then loaded with MitoTracker red, and dual imaging was performed using a confocal microscope. A washout period of 1-2 h was sufficient to decrease the initially uniform cytoplasmic fluorescence of DDF to the almost undetectable level, whereas DDF was retained in mitochondria, colocalizing with MitoTracker (merged images). B: HUVEC were incubated for 24-48 h in the presence of 30 mM D-glucose (n = 11), 25 mM L-glucose + 5 mM D-glucose (n = 10), or 5 mM D-glucose (n = 11) and pulse chase loaded with DDF, and mitochondrial fluorescence was monitored. Application of A-23187 (5 µg/ml) resulted in a modest increase in DDF fluorescence intensity of HUVEC exposed to 5 mM D-glucose or 30 mM L-glucose. In contrast, the same concentration of A-23187 elicited a robust fluorescence response in cells cultured in high D-glucose. *P < 0.05 compared with 5 mM D-glucose. C: treatment of HUVEC cultured in 30 mM D-glucose for 24 h with Mn-TBAP (50 µM) completely abolished the DDF response to the calcium ionophore. *P < 0.05 compared with Mn-TBAP-treated cells. D: superoxide production by isolated liver mitochondria from diabetic and control rats. Isolated mitochondrial preparations were obtained from the liver of ZDF and control ZL rats. Mitochondria were loaded with DDF and stimulated with A-23187. Fluorescence was detected with a plate reader at different times after the stimulation. Note that superoxide production by mitochondria obtained from ZDF rats was significantly elevated under basal conditions and increased further after stimulation with A-23187. *P < 0.05, ZDF vs. ZL rats, n = 11 in each group.

Hyperglycemic environment switches mtNOS from a NO-generating to a superoxide-producing enzyme. To assess the source(s) of A-23187-triggerred production of superoxide anions in D-glucose-treated HUVEC, cells were pretreated with antimycin A (to block the pathway to complex III, cytochrome c, and complex IV) or L-NNA (to block any possible superoxide production by NOS). As shown in Fig. 8, the increased basal DDF fluorescence in HUVEC incubated with 30 mM D-glucose (but not the equivalent concentration of L-glucose), even before the application of A-23187, was attenuated by L-NNA (1 mM) and virtually returned to the control level with pretreatment with antimycin (10 µM). In contrast, a further increase in mitochondrial superoxide generation induced by A-23187 in HUVEC incubated with 30 mM D-glucose (but not with 30 mM L-glucose) was abolished by L-NNA and attenuated by antimycin, suggesting that the respiratory chain is the major source of superoxide anions under basal conditions and that mtNOS is the major source of superoxide anions under the stimulated conditions modeled by calcium overload.


View larger version (19K):
[in this window]
[in a new window]
  		Fig. 8.   The contribution of NOS and the mitochondrial respiratory chain to superoxide generation in HUVEC cultured at high or normal D-glucose. HUVEC were cultured with the addition of 30 mM D-glucose or L-glucose in 96-well clusters, mitochondria were loaded with DDF, and cells were treated with either L-NNA or antimycin (AM), as detailed in METHODS. The basal fluorescence intensity was detected using a fluorescence plate reader. In 5 mM D-glucose-treated (n = 12) and L-glucose-treated (n = 12) HUVEC, treatment with L-NNA or AM did not produce any significant changes in basal fluorescence intensity. In 30 mM D-glucose-treated cells (n = 12), the basal fluorescence intensity was significantly increased over control; L-NNA pretreatment attenuated it, whereas AM pretreatment completely reversed it. The same preparations were treated with A-23187, and the intensity of mitochondrial DDF fluorescence was reexamined. Administration of A-23187 (5 µg/ml, 1 min) resulted in a modest increase in DDF fluorescence of control preparations, which was inhibited by AM. In mitochondria of the high D-glucose group (but not those from L-glucose), A-23187 resulted in a significant increase in DDF fluorescence. Pretreatment with L-NNA virtually abolished any calcium ionophore-induced increase in DDF fluorescence, whereas AM attenuated the response to A-23187.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study provides a complementary set of experimental data on mitochondrial generation of NO or O<UP><SUB>2</SUB><SUP>−</SUP></UP> by endothelial cells exposed to normal (5 mM) or high (30 mM) glucose concentrations and by HEK/eNOS cells as well as by liver mitochondria isolated from ZDF rats. A remarkable reciprocity in the ability to generate these products appears to exist in the mitochondria: conditions leading to the increased production of O<UP><SUB>2</SUB><SUP>−</SUP></UP> are associated with the suppression of NO. Could these processes be functionally coupled?

Mitochondrial generation of NO by an intrinsic NOS has been documented in several studies (2, 3, 13, 14, 19). Our data demonstrated immunodetectable eNOS in the mitochondrial fractions of HUVEC and HEK/eNOS (but not wild-type HEK) cells. In addition, we recently provided evidence for eNOS binding to the outer mitochondrial membrane of HUVEC and HEK/eNOS cells (S. Gao, unpublished observations), further implying that NO detected in mitochondria arises from the local rather than the plasmalemmal source.

Known pathways of mitochondrial O<UP><SUB>2</SUB><SUP>−</SUP></UP> generation include NADH dehydrogenase at complex I and ubiquinone-complex III (21). It has been demonstrated that hyperglycemia produces oxidant stress in endothelial cells and antioxidants prevent intracellular formation of advanced glycation endproducts (12, 32). Previous studies by Nishikawa et al. (25) have provided evidence that the tricarbocylic acid cycle rather than the malate-aspartate shuttle was mainly responsible for the oxidant stress in hyperglycemic endothelial cells. These authors have also demonstrated that a cell-permeable form of Mn-SOD not only reduced oxidant stress in hyperglycemia but also suppressed formation of sorbitol, advanced glycation endproducts, and activity of protein kinase C. Our data obtained with a superoxide dismutase mimetic, Mn-TBAP, are consistent with this observation. In addition, we demonstrated that mitochondrial O<UP><SUB>2</SUB><SUP>−</SUP></UP> production was suppressed by the inhibition of NOS, thus raising the question of the contribution of mtNOS to the oxidant stress.

Several technical aspects of our studies and their interpretation deserve further elucidation. First, DAF is not an ideal NO reporter. As noted above, this indicator is light and calcium activatable (4). The former obstacle can be attenuated by minimizing the illumination (lower energy and shorter exposure), the strategy that was employed in our study. The latter property compounds the interpretation of results by creating uncertainty as to the causes of increased NO readout: artifact related to the NO-independent activation of DAF or calcium-induced stimulation of eNOS. The observation that the DAF fluorescence yield was decreased after treatment with L-NAME, but not D-NAME, despite the fact that calcium underwent similar pharmacological manipulations, argues in favor of calcium activation of eNOS. Utility of DDF as a ROS indicator has recently been questioned on the basis of findings that heme and hemoproteins or glycated albumin may interfere with the fluorescence quantum yield and that this indicator may stimulate per se the formation of ROS (26, 28, 33). However, the impact of these serious drawbacks on the fidelity of results was minimized in our experiments by performing parallel studies in resting, A-23187-stimulated, and L-NAME-treated mitochondria. The simultaneous analysis of all these variables allowed us to draw conclusions on the direction of ROS changes.

There is ample evidence that NOS can function as a NO-generating or as an O<UP><SUB>2</SUB><SUP>−</SUP></UP>-generating enzyme, the latter being a result of uncoupling of oxygen reduction and arginine oxidation by NOS (16, 28, 37, 38). Du et al. (10) indicated that high glucose leads to an increase in generation of reactive oxygen intermediates, which can be prevented not only by antioxidants but also by L-NNA. In contrast, Graier et al. (15) reported that increased superoxide formation by high D-glucose as well as by a nonmetabolizable D-glucose analog, 3-O-methylglucopyranose, was insensitive to L-NNA. In our experiments, production of ROS was also uninhibitable by L-NNA under unstimulated conditions but became inhibitable only after stimulation. The fact that L-NNA inhibited not only mitochondrial NO production but also the generation of ROS argues in favor of the idea that, in hyperglycemia, the enzyme is uncoupled rather than NO is merely scavenged by superoxide. Experiments designed to stimulate mtNOS by increasing calcium influx demonstrated that this resulted in NO generation by endothelial cells maintained in the normoglycemic environment, whereas the similar stimulation of cells kept in the hyperglycemic environment resulted in the diminished NO production and markedly enhanced O<UP><SUB>2</SUB><SUP>−</SUP></UP> generation. In addition, pretreatment with L-NNA, which had only a partial effect in suppressing O<UP><SUB>2</SUB><SUP>−</SUP></UP> generation in normoglycemia, resulted in a dramatic inhibition of O<UP><SUB>2</SUB><SUP>−</SUP></UP> generation in hyperglycemic endothelial cells, especially after calcium stimulation. Investigations by Hotta et al. (17) demonstrated that intramitochondrial calcium concentration, as measured with fura 2 in myocardial mitochondrial preparations, was not significantly affected by NOS inhibition under steady-state conditions. Of note, these data obtained intravitally were corroborated by the results of experiments in isolated mitochondria, thus reducing the chance that NO and O<UP><SUB>2</SUB><SUP>−</SUP></UP> generated at the plasma membrane diffused into fluorophore-loaded mitochondria in the whole cell.

While the excessive generation of ROS has been shown to activate protein kinase C, induce aldose reductase activity, stimulate formation of advanced glycation endproducts and activate NF-kappa B (25), the consequences of reduced mitochondria-associated production of NO readily complement this list. Specifically, it has been demonstrated that NO suppresses aldose reductase activity (6) and inhibits the formation of advanced glycation endproducts (1).

In addition to these actions, endogenous NO has been shown to regulate the activity of cytochrome c oxidase (13, 14). Nanomolar concentrations of NO have been shown to increase the apparent Michaelis-Menten constant of cytochrome oxidase for oxygen, in both isolated mitochondria and cultured endothelial cells, and transiently decrease oxygen consumption (5, 7). These cellular data correspond well with the whole animal findings demonstrating that inhibition of NO increases total oxygen consumption (30, 31). It can be deduced, therefore, that under hyperglycemic conditions, endothelial cells exhibit dysregulation of this mechanism adjusting oxygen consumption to its availability. Indeed, this prediction is supported by the recent demonstration that bradykinin- or carbachol-induced inhibition of oxygen consumption is impaired in diabetic heart muscle in the dog (42) and in the retina of diabetic patients without retinopathy during hyperglycemia (34). In addition, the combination of oxidative and nitrosative stress, leading to peroxynitrite formation, results in the irreversible inhibition of mitochondrial respiration through the iron-sulfur centers of complexes I and II of the respiratory chain (39). Our findings of the functional switch of mtNOS from a NO-generating to an O<UP><SUB>2</SUB><SUP>−</SUP></UP>-generating enzyme may also explain the observed failure to regulate oxygen consumption in diabetes.


    ACKNOWLEDGEMENTS

The authors express gratitude to Dr. S. S. Gross (Cornell Medical Center) for helpful discussions and criticism of the manuscript.


    FOOTNOTES

These studies were supported in part by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-52783, DK-45462, and DK-54602 (to M. S. Goligorsky), by American Heart Association Fellowship 0120200T (to S. V. Brodsky), and by the National Kidney Foundation (to H. Li).

Address for reprint requests and other correspondence: M. S. Goligorsky, New York Medical College, Dept. of Medicine, Basic Sciences Bldg., Valhalla, NY 10595 (E-mail: Michael_Goligorsky{at}nymc.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

July 26, 2002;10.1152/ajpheart.00196.2002

Received 6 March 2002; accepted in final form 23 July 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Asahi, K, Ichimori K, Nakazawa H, Izuhara Y, Inagi R, Watanabe T, Miyata T, and Kurokawa K. Nitric oxide inhibits the formation of advanced glycation end products. Kidney Int 58: 1780-1787, 2000[Web of Science][Medline].

2.   Bates, TE, Loesch A, Burnstock G, and Clark JB. Immunocytochemical evidence for a mitochondrially located nitric oxide synthase in brain and liver. Biochem Biophys Res Commun 213: 869-900, 1995[Web of Science][Medline].

3.   Bates, TE, Loesch A, Burnstock G, and Clark JB. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218: 40-44, 1996[Web of Science][Medline].

4.   Broillet, MC, Randin O, and Chatton JY. Photoactivation and calcium sensitivity of the fluorescent NO indicator 4,5-diaminofluorescein: implications for cellular NO imaging. FEBS Lett 491: 227-232, 2000.

5.   Brown, GC, and Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356: 295-298, 1994[Web of Science][Medline].

6.   Chandra, A, Srivastava S, Petrash J, Bhatnagar A, and Srivastava SK. Active site modification by aldose reductase by nitric oxide donors. Biochim Biophys Acta 1341: 217-222, 1997[Medline].

7.   Clementi, E, Brown G, Foxwell N, and Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA 96: 1559-1562, 1999[Abstract/Free Full Text].

8.   Cosentino, F, and Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91: 139-144, 1995[Abstract/Free Full Text].

9.   Croze, EM, and Morre DJ. Isolation of plasma membrane, Golgi apparatus, and endoplasmic reticulum fractions from single homogenates of mouse liver. J Cell Physiol 119: 46-57, 1984[Web of Science][Medline].

10.   Du, X, Stockklauser-Färber K, and Rösen P. Generation of reactive oxygen intermediates, activation of NF-kappa B, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med 27: 752-763, 1999[Web of Science][Medline].

11.   Furchgott, RF, and Zawadzki JW. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980[Medline].

12.   Giardiano, I, Edelstein D, and Brownlee M. Bcl-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97: 1422-1428, 1996[Web of Science][Medline].

13.   Giulivi, C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J 332: 673-679, 1998[Web of Science][Medline].

14.   Giulivi, C, Poderoso JJ, and Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 273: 11038-11043, 1998[Abstract/Free Full Text].

15.   Graier, WF, Simecek S, Kukovetz WR, and Kostner GM. High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45: 1386-1395, 1996[Abstract].

16.   Hobbs, AJ, Fukuto J, and Ignarro LJ. Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proc Natl Acad Sci USA 91: 10992-10996, 1994[Abstract/Free Full Text].

17.   Hotta, Y, Otsuka-Murakami H, Fujita M, Nakagawa J, Yajima M, Liu W, Ishikawa N, Kawai N, Masumizu T, and Kohno M. Protective role of nitric oxide synthase against ischemia-reperfusion injury in guinea pig myocardial mitochondria. Eur J Pharmacol 380: 37-48, 1999[Web of Science][Medline].

18.   Ignarro, LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269, 1987[Abstract/Free Full Text].

19.   Kobzik, L, Stringer B, Balligand JL, Reid MB, and Stamler JS. Endothelial nitric oxide synthase in skeletal muscle fibers: mitochondrial relationships. Biochem Biophys Res Commun 211: 375-381, 1995[Web of Science][Medline].

20.   Kojima, H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, and Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70: 2446-2453, 1998[Medline].

21.   Kwong, L, and Sohal R. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch Biochem Biophys 350: 118-126, 1998[Web of Science][Medline].

22.   Li, H, Brodsky S, Basco M, Romanov V, De Angelis D, and Goligorsky MS. Nitric oxide attenuates signal transduction: possible role in dissociating caveolin-1 scaffold. Circ Res 88: 229-236, 2001[Abstract/Free Full Text].

23.   Li, WP, Liu P, Pilcher BK, and Anderson RG. Cell-specific targeting of caveolin-1 to caveolae, secretory vesicles, cytoplasm or mitochondria. J Cell Sci 114: 1397-1408, 2001[Abstract].

24.   Liu, J, Garcia-Cardena G, and Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolar localization. Biochemistry 35: 13277-13281, 1996[Medline].

25.   Nishikawa, T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404: 787-790, 2000[Medline].

26.   Ohashi, T, Mizutani A, Murakami A, Kojo S, Ishii T, and Taketani S. Rapid oxidation of dichloroluorescin with heme and hemoproteins: formation of the fluorescein is independent of the generation of reactive oxygen species. FEBS Lett 511: 21-27, 2002[Web of Science][Medline].

27.   Palmer, RM, Ashton DS, and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988[Medline].

28.   Pou, S, Pou W, Bredt D, Snyder SH, and Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173-24176, 1992[Abstract/Free Full Text].

29.   Rota, C, Fann Y, and Mason RP. Phenoxyl free radical formation during the oxidation of the fluorescent dye 2',7'-dichlorofluorescein by horseradish peroxidase. J Biol Chem 274: 28161-28168, 1999[Abstract/Free Full Text].

30.   Shen, W, Hintze TH, and Wolin MS. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 92: 3505-3512, 1995[Abstract/Free Full Text].

31.   Shen, W, Xu X, Ochoa M, Zhao G, Wolin MS, and Hintze TH. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res 75: 1086-1095, 1994[Abstract/Free Full Text].

32.   Shinozaki, K, Kashiwagi A, Nishio Y, Okamura T, Yoshida Y, Masada M, Toda N, and Kikkawa R. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/superoxide imbalance in insulin-resistant rat aorta. Diabetes 48: 2437-2445, 1999[Abstract].

33.   Subramaniam, R, Fan X, Scivittaro V, Yang J, Ha C, Petersen C, Surewicz W, Bhagavan N, Weiss M, and Monnier VM. Cellular oxidant stress and advanced glycation endproducts of albumin: caveats of the dichlorofluorescein assay. Arch Biochem Biophys 400: 15-25, 2002[Web of Science][Medline].

34.   Tiedeman, J, Kirk S, Srinivas S, and Beach JM. Retinal oxygen consumption during hyperglycemia in patient with diabetes without retinopathy. Ophthalmology 105: 31-36, 1998[Web of Science][Medline].

35.   Torres, M, and Forman HJ. Nitric oxide, oxidative stress, and signal transduction. In: Nitric Oxide: Biology and Pathobiology, edited by Ignarro LJ.. San Diego, CA: Academic, 2000, p. 329-342.

36.   Tsukahara, H, Gordienko D, Gelato M, and Goligorsky MS. Direct demonstration of the IGF-1-induced nitric oxide production by endothelial cells. Kidney Int 45: 598-604, 1994[Web of Science][Medline].

37.   Vasquez-Vivar, J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, and Pritchard KA, Jr. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225, 1998[Abstract/Free Full Text].

38.   Xia, Y, Dawson V, Dawson T, Snyder S, and Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93: 6770-6774, 1996[Abstract/Free Full Text].

39.   Xie, YW, and Wolin MS. Role of nitric oxide and its reaction with superoxide in the suppression of cardiac muscle mitochondrial respiration: involvement in response to hypoxia/reoxygenation. Circulation 94: 2580-2586, 1996[Abstract/Free Full Text].

40.   Yuan, L, Inoue S, Saito Y, and Nakajima O. An evaluation of the effects of cytokines on intracellular oxidative production in normal neutrophils by flow cytometry. Exp Cell Res 209: 375-381, 1993[Web of Science][Medline].

41.   Zhang, X, Li H, Jin H, Ebin Z, Brodsky S, and Goligorsky MS. Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 279: F671-F678, 2000[Abstract/Free Full Text].

42.   Zhao, G, Zhang X, Xu X, Wolin M, and Hintze TH. Depressed modulation of oxygen consumption by endogemous nitric oxide in cardiac muscle from diabetic dogs. Am J Physiol Heart Circ Physiol 279: H520-H527, 2000[Abstract/Free Full Text].

Am J Physiol Heart Circ Physiol 283(5):H2130-H2139
0363-6135/02 $5.00 Copyright © 2002 the American Physiological Society


This article has been cited by other articles:


Home page
 J. Physiol.Home page
E. N. Dedkova and L. A. Blatter
Characteristics and function of cardiac mitochondrial nitric oxide synthase
J. Physiol., February 15, 2009; 587(4): 851 - 872.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Physiol Rev, January 1, 2009; 89(1): 27 - 71.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Y.-H. Chen, S.-J. Lin, F.-Y. Lin, T.-C. Wu, C.-R. Tsao, P.-H. Huang, P.-L. Liu, Y.-L. Chen, and J.-W. Chen
High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide-Related but Not Oxidative Stress-Mediated Mechanisms
Diabetes, June 1, 2007; 56(6): 1559 - 1568.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. X. Zhang and D. D. Gutterman
Mitochondrial reactive oxygen species-mediated signaling in endothelial cells
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2023 - H2031.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M. A. Atkinson, R. J. Johnson, and B. Croker
Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 539 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Nakagawa, W. Sato, Y. Y. Sautin, O. Glushakova, B. Croker, M. A. Atkinson, C. C. Tisher, and R. J. Johnson
Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 736 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
L. G. Kevin, E. Novalija, and D. F. Stowe
Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice
Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. V. Brodsky, F. Zhang, A. Nasjletti, and M. S. Goligorsky
Endothelium-derived microparticles impair endothelial function in vitro
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1910 - H1915.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
E. N. Dedkova, X. Ji, S. L. Lipsius, and L. A. Blatter
Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells
Am J Physiol Cell Physiol, February 1, 2004; 286(2): C406 - C415.
[Abstract] [Full Text]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/5/H2130    most recent
00196.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodsky, S. V.
Right arrow Articles by Goligorsky, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodsky, S. V.
Right arrow Articles by Goligorsky, M. S.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online